PI3K-independent mTOR activation promotes lapatinib resistance and IAP expression that can be effectively reversed by mTOR and Hsp90 inhibition
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Pharmacology,Oncology,Molecular Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/15384047.2014.1002693
Reference52 articles.
1. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
2. Molecular predictors of response to trastuzumab and lapatinib in breast cancer
3. Resistance to HER2-directed antibodies and tyrosine kinase inhibitors
4. Treatment of HER2-positive breast cancer: current status and future perspectives
5. Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells;International Journal of Molecular Sciences;2024-03-09
2. Artemisia argyi extracts overcome lapatinib resistance via enhancing TMPRSS2 activation in HER2‐positive breast cancer;Environmental Toxicology;2024-03-06
3. Overcoming brain-derived therapeutic resistance in HER2+ breast cancer brain metastasis;2024-02-22
4. FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2;Scientific Reports;2023-12-08
5. FilGAP regulates tumor growth in Glioma through the regulation of mTORC1 and mTORC2;2023-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3